Year 2019 (53)

Edition nr. 3

Hydrochlorothiazide and skin cancer: a debatable warning?

Dutch care providers and patients were confronted in October 2018 by a nationwide warning about a “slightly increased” risk of squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) when using hydrochlorothiazide. Although there was no need ...

In short Read article

Ribociclib in breast cancer

Ge-Bu usually discusses new drugs that are going to be frequently used after a recent registration. Hence, one might not expect it to discuss a new drug like ribociclib, as this drug is to be used for metastasised breast cancer, and always in com ...

In short Read article